The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems
Acta Pharmaceutica Sinica B
; (6): 961-977, 2021.
Article
in En
| WPRIM
| ID: wpr-881178
Responsible library:
WPRO
ABSTRACT
As one of the most important components of caveolae, caveolin-1 is involved in caveolae-mediated endocytosis and transcytosis pathways, and also plays a role in regulating the cell membrane cholesterol homeostasis and mediating signal transduction. In recent years, the relationship between the expression level of caveolin-1 in the tumor microenvironment and the prognostic effect of tumor treatment and drug treatment resistance has also been widely explored. In addition, the interplay between caveolin-1 and nano-drugs is bidirectional. Caveolin-1 could determine the intracellular biofate of specific nano-drugs, preventing from lysosomal degradation, and facilitate them penetrate into deeper site of tumors by transcytosis; while some nanocarriers could also affect caveolin-1 levels in tumor cells, thereby changing certain biophysical function of cells. This article reviews the role of caveolin-1 in tumor prognosis, chemotherapeutic drug resistance, antibody drug sensitivity, and nano-drug delivery, providing a reference for the further application of caveolin-1 in nano-drug delivery systems.
Full text:
1
Index:
WPRIM
Type of study:
Prognostic_studies
Language:
En
Journal:
Acta Pharmaceutica Sinica B
Year:
2021
Type:
Article